An interventional study of Non-invasive application of i PRF and Non-surgical endodontic and periodontal treatment in Endodontic-Periodontal Lesions, sponsored by Cairo University. Not yet recruiting at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2026-11-10.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
To compare the effect of non-invasive injectable PRF application on periodontal healing in Grade 2-3 endodontic periodontal lesions.
Hypothesis: No difference in healing outcome between the two groups. Outcome measure 1: (Primary outcome)
Periodontal healing as demonstrated by change in Clinical Attachment Level (CAL)
Secondary outcomes:
Inclusion criteria:
Presence of a periodontal-endodontic lesion (EPL without root damage in non-periodontitis patients) according to (Herrera et al., 2018) confirmed by:
Exclusion criteria:
A. Preoperative patient assessment:
B. Diagnostic procedure:
Medical history will be taken first through a series of questions (Appendix 3).
Dental history: Determination of history of pain, trauma, dental cracks, root canal therapy, periodontal mechanical therapy, or orthodontic therapy (Appendix 4).
Clinical Examination:
Determination of tenderness on percussion and occlusion, periodontal condition, pulp and periapical condition, and occlusion (Chen et al., 2024).
Pulp and periapical condition:
Periodontal condition:
A periodontal probe will be used to take the periodontal clinical measurements from six sites of the teeth of interest (distolingual, mid-lingual, mesiolingual distobuccal, midbuccal and mesiobuccal), (Appendix 2).
Grade 1: First noticeable sign of movement greater than normal
Grade 2: Tooth movement of greater than 1 mm in any direction.
Grade 3: Tooth movement of greater than 1 mm in any direction, combined with vertical mobility within the tooth socket.
Radiographic Examination:
The diagnosis of endodontic-periodontal lesions without root damage is based on the following criteria:
If the patient meets the clinical eligibility criteria, an informed consent will be taken from the patient prior to performing any treatment.
The patient will be given a scheduled appointment for all the visits needed to ensure compliance till the end of the trial.
C. Full mouth Professional Mechanical Plaque Removal (PMPR) will be done using an ultrasonic device 1 week before the 2nd endodontic appointment.
D. Endodontic treatment protocol:
First visit:
Non-surgical RCT will be carried out in 2 appointments (Duque et al., 2018; Gill et al., 2023). The tooth will be anaesthetized using inferior alveolar nerve block technique using mepivacaine hydrochloride 2% with 1:100,000 epinephrine . Access cavity will be performed using a round bur and an endo-z bur. The tooth will be properly isolated using rubber dam. Working length will be determined using an apex locator . Intracanal irrigation will be done using 5.25% sodium hypochlorite solution. Cleaning and shaping of the canals will be performed using engine-driven rotary instruments. Canals will be medicated with Calcium hydroxide (Metapaste) . The access cavity will then be sealed with a temporary restoration.
Second visit:
At the second visit calcium hydroxide intracanal medicament will be removed followed by a final rinse protocol using 1 ml EDTA 17% for 1 minute followed by 3 ml 5.25% NaOCl. Canals will then be obturated using a master gutta percha cone and thermoplastisized gutta percha technique and resin-based sealer . The tooth will then be sealed with a final composite restoration.
E. Minimally invasive Non-Surgical Periodontal Treatment (MINST):
MINST (Nibali et al., 2019; Mehta et al., 2024) will follow root canal treatment (Gupta et al., 2015; Evans, 2023; Gill et al., 2023). The therapeutic procedure will be performed under local anesthesia3, using a delicate tip power-driven instrument P3 tip (Guilin Woodpecker, Guilin, China), (Nibali et al., 2015, 2019).
After the MINST procedure, allocation was performed according to the computerized randomization table, and i-PRF was administered into the pockets to the patients allocated to the intervention group.
Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Presence of a periodontal-endodontic lesion (EPL without root damage in non-periodontitis patients) according to (Herrera et al., 2018) confirmed by:
Exclusion Criteria:
Presence of one narrow deep periodontal pocket around the affected tooth (EPL Grade 1)
Cases will undergo root canal treatment plus non-surgical periodontal treatment followed by Non-invasive application of injectable PRF in periodontal pockets
Procedure: Non-invasive application of i PRF · Procedure: Non-surgical endodontic and periodontal treatment
Procedure: Non-surgical endodontic and periodontal treatment
Non-invasive application of i PRF in endodontic-periodontal lesions
Non-surgical endodontic treatment followed by non-surgical periodontal treatment
Clinical Attachment Level
Periodontal parameters will be measured using UNC periodontal probe
Time frame: 6 months
Change in Pocket probing depth (PPD)
Time frame: 6 months
Gingival recession
Time frame: 6 months
Radiographic defect fill
Time frame: 6 months
Tooth mobility
Time frame: 6 months
Bleeding on probing
Time frame: 6 months
Plaque index
Time frame: 6 months
Plan to share: Undecided
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.